SHMT2 and acute lymphoblastic leukemia: Given the selective dependency of T-ALL on the one-carbon folate pathway, strong correlation of SHMT1 and SHMT2 expression with enrichment for the one-carbon folate pathway in T-ALL, and availability of a novel inhibitor, we evaluated targeting this pathway using RZ-2994 [5] (also known as SHIN1 [19]).